| Name | Title | Contact Details |
|---|
Lead Edge Capital is an innovative, multi-stage growth equity firm that offers entrepreneurs flexible capital and extensive domain expertise via its Limited Partner Network, a global advisory group of leading executives, entrepreneurs and dealmakers.
Leaders in private equity, debt and real estate ownership and financing, the Gladstone Companies are a family of public investment funds. Our funds as applicable, invest in commercial real estate, farmland, and small and medium-sized companies and provide financing to such businesses across the capital structure, from second lien and mezzanine debt, to equity and real estate financing solutions. Financing for the Gladstone Companies is provided by four public investment vehicles: Gladstone Capital Corporation (NASDAQ: GLAD), Gladstone Investment Corporation (NASDAQ: GAIN), Gladstone Commercial Corporation (NASDAQ: GOOD), and Gladstone Land Corporation (NASDAQ: LAND). Target investments generally range from $5 to $30 million in companies with over $3 million in EBITDA. Target Industries: Light and Specialty Manufacturing, Industrial Products and Services, Business and Government Services, Aerospace and Defense, Media and Communications, Consumer Products and Services, Healthcare Services, Transportation and Logistics, Specialty Chemicals and Energy Services.
Office of Cnslt on Lgal Edcatn is a Indianapolis, IN-based company in the Financial Services sector.
Andrew Garrett Inc is a New York, NY-based company in the Financial Services sector.
Omega Funds is a leading international investment firm that creates and invests in life sciences companies that target the world`s most urgent medical needs. Ω is the last letter of the Greek alphabet. Our investment process starts by focusing on the end goal – delivering impactful medicines to patients. We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas, including oncology, immunology, rare diseases, precision medicine and others. Early seed or late stage public financing. Large markets or rare diseases. Established targets or novel technologies. We are guided by our conviction in people, products and breakthrough ideas, not by conventional categories. Our investments span a variety of instruments from early venture rounds, to late-stage investing, direct secondary transactions, as well as company founding and creation. Omega Funds has raised more than $1 billion since its inception in 2004 and is headquartered in Boston, Massachusetts, USA.